Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Azithromycin vs Doxycycline for Posterior Blepharitis
NCT01783860Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in posterior blepharitis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Change of Blepharitis Symptoms Score at 61 days and Change of Symptoms and Signs Scores (Total Severity Score) at 61 days. Started Jan 2013; status: completed.
02
Drugs
azithromycin
03
Conditions
posterior blepharitis
Beyond the preview
Go deeper on NCT01783860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783860.